Insights from SARS-CoV-2 nanopore genomic surveillance in Edo State, Nigeria
Résumé
Abstract In response to the COVID-19 pandemic, local SARS-CoV-2 nanopore sequencing capacity was established at Irrua Specialist Teaching Hospital (ISTH), a Lassa fever reference centre based in Edo State, Nigeria. This was enabled through training of local staff in Nigeria and Guinea in both laboratory and bioinformatic SARS-CoV-2 sequencing protocols. Between March 2020 and December 2023, the laboratory at ISTH conducted 29,643 diagnostic tests for SARS-CoV-2, of which 4,575 (15.4%) were positive. Between April and December 2022, 410 SARS-CoV-2 positive samples were selected and retrospectively sequenced in 19 runs. From these, 213 near-complete (> 93%) viral genomes were generated and submitted to GISAID. Phylogenetic and phylogeographic analyses supported that Nigeria served simultaneously as a source and recipient of SARS-CoV-2 lineages, driving global spread of the AY.36 Delta variant and receiving Omicron sublineages (BA.1.1 and BQ.1) from North America and Europe. Here we show that a pre-existing long-term laboratory capacity development program for Lassa virus, a high-risk pathogen, facilitated the successful integration of novel workflows for a new emerging pathogen.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 16/11/2026. Le document reste hébergé par sa source.
Voir le document à la source →